Who founded Gesynta Pharma?

Gesynta Pharma was founded by Patric Stenberg, Gunilla Ekström.

Who are Gesynta Pharma's investors?

Gesynta Pharma's investors include Amboy Street Ventures, Foreground Capital, Hadean Ventures, HealthCap, Industrifonden, XGEN Venture, Catalyze Capital.

How much funding has Gesynta Pharma raised?

Gesynta Pharma has disclosed $28M raised across 1 of its 3 known rounds.

Where is Gesynta Pharma headquartered?

Gesynta Pharma is headquartered in Stockholm, SE.

Gesynta Pharma

Stockholm, SE · 7 known investors

Find your way into Gesynta Pharma

Paths you didn't know you had: your email and LinkedIn already hold routes to the Gesynta Pharma team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis. Its pipeline targets inflammation- and pain-related conditions across clinical development stages.

Biotech Digital Health FemTech Medical Devices

Founders & leadership

Patric StenbergFounder

Gunilla Ekström FounderGunilla Ekström has held roles spanning pharmaceutical R&D, project management, and executive leadership, including positions as a drug metabolism scientist, portfolio director overseeing analgesic compounds from discovery through clinical phase 2, CEO of a virtual pharmaceutical company, and board member at multiple life sciences firms. She has experience across the full R&D value chain from small to large pharma organizations, including investor relations and strategic financing.

Investors · 7

Amboy Street Ventures✓ confirmed by Gesynta PharmaVenice

How we know: the company's own site · the VCSheet dataset · Not right? Tell us

Foreground Capital✓ confirmed by Gesynta PharmaBoston

How we know: Foreground Capital's portfolio page · the company's own site · Not right? Tell us

Hadean Ventures✓ confirmed by Gesynta PharmaOslo

How we know: Hadean Ventures's portfolio page · the company's own site · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

HealthCap✓ confirmed by Gesynta PharmaStockholm

How we know: the company's own site · HealthCap's portfolio page · funding news · Not right? Tell us

Industrifonden✓ confirmed by Gesynta PharmaStockholm · $960K – $4.8M

How we know: Industrifonden's portfolio page · the company's own site · funding news · Not right? Tell us

XGEN Venture✓ confirmed by Gesynta PharmaMilan

How we know: the company's own site · Not right? Tell us

Catalyze Capitallisted by Catalyze CapitalAmsterdam · $1.6M

Funding

SEC filings, press & company announcements

$28M disclosed across 1 of 3 rounds · 2025

Undisclosed amountSeries BJul 2025
Source ↗
Undisclosed amountSeries BJan 2025
Source ↗
$28MraisedJan 2025 · 3 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Gesynta Pharma do?: Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis. Its pipeline targets inflammation- and pain-related conditions across clinical development stages.
Who founded Gesynta Pharma?: Gesynta Pharma was founded by Patric Stenberg, Gunilla Ekström.
Who are Gesynta Pharma's investors?: Gesynta Pharma's investors include Amboy Street Ventures, Foreground Capital, Hadean Ventures, HealthCap, Industrifonden, XGEN Venture, Catalyze Capital.
How much funding has Gesynta Pharma raised?: Gesynta Pharma has disclosed $28M raised across 1 of its 3 known rounds.
Where is Gesynta Pharma headquartered?: Gesynta Pharma is headquartered in Stockholm, SE.